Verastem | VSTM - Operating Expenses

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $37.03M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Alaunos Therapeutics USD 1.19M 428K Sep/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Cytokinetics USD 168.69M 9.58M Sep/2025
Gilead Sciences USD 4.96B 707M Dec/2025
Incyte USD 1.12B 3.53B Dec/2025
Laboratory Of America USD 3.17B 101.7M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
TG Therapeutics USD 132.34M 26.04M Sep/2025
Verastem USD 37.03M 8.97M Sep/2024